Relationship among soluble CD105, hypersensitive C-reactive protein and coronary plaque morphology: An intravascular ultrasound study

Chinese Medical Journal

Volumn 121, Issue 2, 2008, Pages 128-132

  Cui, Song ^a   Lü, Shu Zheng ^a   Chen, Yun Dai ^a   He, Guo Xiang ^b   Meng, Li Jun ^c   Liu, Jian Ping ^b   Song, Zhi Yuan ^b   Liu, Xian Liang ^b   Song, Xian Tao ^a   Ge, Chang Jiang ^a   Liu, Hong ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Binzhou Central Hospital   (China)

Author keywords

Hypersensitive C reactive protein; Intravascular ultrasound; Neovascularization; Soluble CD105

Indexed keywords

C REACTIVE PROTEIN; ENDOGLIN;

ACCURACY; ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DISSECTION; ARTICLE; ATHEROSCLEROTIC PLAQUE; BLOOD SAMPLING; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART VENTRICLE REMODELING; HUMAN; INTRAVASCULAR ULTRASOUND; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STABLE ANGINA PECTORIS; THROMBOGENESIS; UNSTABLE ANGINA PECTORIS;

EID: 39049090121     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200801020-00007     Document Type: Article

References (28)

1. Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the Vulnerable plaque. J Am Coll Cardiol 2006; 47 (8 Suppl): C13-C18.
2. Biasucci LM, Liuzzo G, Colizzi C, Rizzello V. Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease. Ital Heart J 2001; 2: 164-171.
3. Sanchis J, Bodi V, Llacer A, Nunez J, Facila L. Ruiz V, et al. Usefulness of C-reactive protein and left ventricular function for risk assessment in survivors of acute myocardial infarction. Am J Cardiol 2004; 15: 766-769.
4. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-919.
5. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106: 1439-1441.
6. Wang CH, Li SH, Weisel; RD, Fedak PW, Dumont AS, Szmitko P, et al. C-reactive protein upgulates angiotensin type1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783-1790.
7. Ikeds U, Shimada K. Matrix metalloproteinases and coronary artery disease. Clin Cardiol 2003; 26: 55-59.
8. Moreno PR, Purushothaman KR, Fuster V, Echeverri D, Truszczynska H, Sharma SK, et al. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability. Circulation 2004; 110: 2032-2038.
9. Torsney E, Charhon R, Parums D, Collis M, Arthur HM. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflamm Res i002; 51: 464-470.
10. Adam PJ, Clesham GJ, Weissberg PL. Expression of endoglin mRNA and protein in human vascular smooth muscle cels. Biochem Biophys Res Commun 1998; 247: 33-37.
11. Conley BA, Smith JD, Guerrero-Esteo M, Bernabeu C, Vary CP. Endoglin,. a TGF-beta receptor associated protein,is expressed by smooth muscle cels in human atherosclerotic plaques. Atherosclerosis 2000; 153: 323-335.
12. Ge J, Chirillo F, Schwedtmann J, Gorge G, Haude M, Baumgart D, et al. Screening of ruptured plaques in patients with coronary artery disease by intravascular ultrasound. Heart 1999; 81: 621-627.
13. Nissen SE. Application of intravascular ultrasound to characterize coronary atrtery disease and assess the progression or regression of atherosclerosis. Am J Cardiol 2002; 89: 21B-31B.
14. Tanaka A, Kawarabayashi T, Nisjhibori Y, Santo T, Nishida Y, Fukuda D, et al. No-reflow phenomenon and lesion morphology in patients with acute myocardial infarction. Circulation 2002; 105: 2148-2152.
15. Sano T, Tanaka A, Namba M, Nishibori Y, Nishida Y, Kawarabayashi T, et al. C-reactive protein and lesion morphology in patients with acute myocardial infarction. Circulation 2003; 108: 282-285.
16. Schoenhagen P, Ziada KM, Kapadia SR, Crowe TD, Nissen SE, Tuzcu EM. Extent and direction of arterial rémodeling in stable and unstable odronary syndromes. Circulation 2000; 101: 598-603.
17. Fuster V, Moreno PR, Fayad ZA, Corti R, Badimon JS, Atherothrombosis and high-risk plaque: part I: evolving concepts. J Am Coll Cardiol 2005; 46: 937-954.
18. Virmani RZ, Kolodgie FD, Burke AP, Finn AV, Gold HK, Tulenko, TN, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of ntraplaque hemorrhage. Arterioscler Thromb Vasc Biol 2005; 25: 2054-2061.
19. Moreno PR, Purushothaman KR, Zias E, Sanz J, Fuster V. Neovascularization in human atherosclerosis. Curr Mol Med 2006; 6: 457-477.
20. Torsney E, Charhon It, Parums D, Collis M, Arthur HM. Inducible expression of human endoglin during inflammation and wound healing in vivo. Inflatum Res 2002; 51: 464-470.
21. Adam PJ, Clesham GJ, Weissberg PL. Expression of endoglin mRNA and protein in human vascular smooth muscle cells Biochem Biophys Res Commun. 1998; 247: 33-37.
22. Cohley BA, Smith ID, Guerrero-Esteo M, Bernabeu C, Vary CP. Endoglin, a TGF-beta receptor associated protein is expressed by smooth muscle cels in human atherosclerotic plaques. Atherosclerosis 2000; 153: 323-335.
23. Ma X, Labinaz M, Goldstein J, Miller H, Keon WJ, Letarte M, et al. Endoglin is overexpressed after arterial injury and is required for transforming growth factor-B-induced inhibition of smooth muscle cell migration. Arterioscler Thromb Vase Biol 2000; 20. 2546-2552.
24. Guerrero-Esteo M, Lastres P, Letamendfa A, Perez-Alvarez MJ, Langa C, Lopez LA, et al. Endoglin overexpression modulates cellular morphology: migration and adhesion of mouse fibrolasts. Eur J Cell Biol 1999; 78. 614-623.
25. Wang JM, Wilson PB, Pye D, Hunter RD. Quantitation of endothelial cell specific protein E-9 employing a single monoclonal antibody in an indirect sandwich ELISA. J Immunol Method 1994; 171: 55-64.
26. Yip HK, Wu CJ, Chang HW, Yang CH, Yeh KH, Chua S, et al. Levels and values of serum high-sensitivity C-reactive protein within 6 hours after the onset of acute myocardial infarction. Chest 2004; 126: 1417-1422.
27. Sugiyama S, Okada Y, Sukhova GK, Virmani R, Heinecke JW, Libby P. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am J Pathol, 2001; 158: 879-891.
28. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Mod 2000; 342: 836-843.